Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 12
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II Trial Now Recruiting, Investigates Microbiome as Immunotherapy Enhancer
Dave Bloom
-
2025/11/21
Anaphylm™ Sublingual Epinephrine Shows Promising Results for Pediatric Anaphylaxis Treatment
Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years
Peanut Sublingual Immunotherapy Shows Long-Term Benefits for Young Children
RAPT Therapeutics Launches Phase 2b Trial for Anti-IgE Therapy for Food Allergies
FDA Approves First Treatment for Eosinophilic Esophagitis (EoE), a Chronic Immune...
News Wire ~ 3rd Party Press Release
-
2022/05/23
0
Prota Therapeutics Achieves 51% Peanut Allergy Remission Rate in Kids with...
News Wire ~ 3rd Party Press Release
-
2022/05/16
0
FDA Accepts Dupixent® (dupilumab) for Priority Review in Patients Aged 12...
News Wire ~ 3rd Party Press Release
-
2022/04/12
0
Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial
Dave Bloom
-
2022/04/06
0
Stealth Mode Company Granted Patent for Sublingual Epinephrine Tablet
Dave Bloom
-
2022/03/25
0
Sublingual Epinephrine for Anaphylaxis Receives Fast Track Designation from FDA
News Wire ~ 3rd Party Press Release
-
2022/03/18
0
FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...
News Wire ~ 3rd Party Press Release
-
2022/03/04
0
CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...
Dave Bloom
-
2022/03/02
0
Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration
Dave Bloom
-
2022/03/01
0
Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients
News Wire ~ 3rd Party Press Release
-
2022/02/28
0
1
...
11
12
13
...
30
Page 12 of 30